Ticker Details
Nurix Therapeutics, Inc.
IPO Date:	July 24, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.73B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.70 | 3.67%
Avg Daily Range (30 D):	$0.51 | 2.05%
Avg Daily Range (90 D):	$0.50 | 2.51%

Institutional Daily Volume
Avg Daily Volume:	.57M
Avg Daily Volume (30 D):	.81M
Avg Daily Volume (90 D):	1.3M

Trade Size
Avg Trade Size (Sh.):	70
Avg Trade Size (Sh.) (30 D):	56
Avg Trade Size (Sh.) (90 D):	65

Institutional Trades
Total Institutional Trades:	2,241
Avg Institutional Trade:	$2.19M
Avg Institutional Trade (30 D):	$2.75M
Avg Institutional Trade (90 D):	$3.17M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.21M
Avg Closing Trade (30 D):	$4.96M
Avg Closing Trade (90 D):	$4.62M
Avg Closing Volume:	126.76K

News

Jul 23, 2026 @ 5:00 PM Molecular Glues Clinical Trial Landscape: 80+ Emer... Source: Delveinsight

Jun 8, 2026 @ 1:26 PM Nurix Therapeutics Gains Ground As Roche Partnersh... Source: Vandana Singh

May 13, 2026 @ 11:00 AM Nurix Therapeutics to Participate in Upcoming Inve... Source: Not Specified

Apr 22, 2026 @ 11:00 AM Nurix Therapeutics Announces New Preclinical Data ... Source: Na

Apr 21, 2026 @ 5:00 PM Follicular Lymphoma Clinical Trial Space Intensifi... Source: Delveinsight

Financials
	TTM	Q2 2026	Q4 2026
Basic EPS	$-3.46	$-.81	$-.79
Diluted EPS	$-3.46	$-.81	$-.79
Revenue	$36.77M	$9.04M	$6.25M
Gross Profit
Net Income / Loss	$-341.35M	$-89.54M	$-87.17M
Operating Income / Loss	$-361.18M	$-94.2M	$-92.5M
Cost of Revenue
Net Cash Flow	$-16.51M	$-3.51M	$-175.77M
PE Ratio